Reuters UK (Free subscription) | yesterday
WASHINGTON (Reuters) - Early data from a 4-year clinical trial show no increased risk of stroke in patients given Pfizer Inc's lung drug Spiriva compared with placebo, the U.S. Food and Drug Administration said on Tuesday.
MSNBC.com: Newsweek Health (Free subscription) | 4 hours ago
Lawsuit charges drugmaker was deceptive about Neurontin.
Indy Star (Free subscription) | 4 hours ago
TRENTON, N.J. » Pfizer told employees worldwide Tuesday it is replacing its current geographic divisions with new ones focused on primary care, specialty care and operations in emerging markets.
Law Blog - WSJ.com (Free subscription) | 4 hours ago
In 2004, Pfizer's Warner-Lambert unit pleaded guilty to felony charges that it promoted Neurontin for uses not approved by the Food and Drug Administration, including bipolar disorder and chronic nerve pain. The FDA originally approved the drug as an antiseizure treatment for epilepsy and in 2002 for one kind of pain related to shingles.
Boston Globe (Free subscription) | 5 hours ago
Top drug company marketing executives suppressed a large European study suggesting their blockbuster medication Neurontin was ineffective for chronic nerve pain, and they privately strategized about how to silence a British researcher who wanted to go public with the data, according to newly filed documents and e-mails that are part of a Boston court case.
Law Blog - WSJ.com (Free subscription) | 6 hours ago
Pfizer plans to create new divisions and move certain drug-development functions into the commercial groups as it seeks to revive growth.
Law Blog (Free subscription) | 9 hours ago
From time to time, companies must confront unwanted advertising. Take the Italian eatery Olive Garden. As reported in this WSJ front-pager , the restaurant has been none too pleased with the “deep love” that Kendra Wilkinson — “a Playboy cover model, television star and one of Hugh Hefner’s three live-in girlfriends” — professes for the family-friendly chain. Pfizer is dealing with a similar situation...
Pharmalot (Free subscription) | 10 hours ago
Say what? This advertising concept may fly right over your head. But a little-known company called JetAngel is locked in a nasty trademark battle with Pfizer after placing the Viva Viagra logo on a missile that was paraded through Manhattan last month and even stopped in front of the drugmaker’s 42nd Street headquarters. Why? JetAngel specializes [...]
PharmaGossip (Free subscription) | yesterday
Pfizer is replacing its current geographic divisions with new ones focused on primary care, specialty care and operations in emerging markets. The new units, which will begin operating at the beginning of next year, will have complete responsibility for functions including strategic planning, sales and marketing, and even drug development process . More
Boston Globe (Free subscription) | yesterday
Pfizer Inc. , continuing its drive to create more focused business units, told employees worldwide Tuesday it is replacing its current geographic divisions with new ones centered on primary care, specialty care and operations in emerging markets.
Forbes (Free subscription) | yesterday
The pharma company is creating three new business units to better serve its constituents.
Star Tribune (Free subscription) | yesterday
Some employees may see slight shifts in their duties, but job cuts are not part of the plan, he said. Under a major restructuring announced in January 2007, the company already has eliminated more than 13,500 jobs, closed numerous plants and reduced annual costs, compared with 2006 levels, by $1.2 billion out of its goal of cutting $2 billion in spending.
Pharmalot (Free subscription) | yesterday
In its latest quest to jumpstart its flagging business, Pfizer is reorganizing most of its operations into three new business units - two that would target primary and specialty care docs, and a third that will focus on so-called emerging markets, particularly the BRIC nations, or Brazil, Russia, India and China. The shuffling of the corporate [...]
World of stocks (Free subscription) | yesterday
TheStreet.com Winners & Losers Financial Winners & Losers: BofA Tech Winners & Losers: AMD 10/7/2008 2:53 PM EDT Health Winners & Losers: Pfizer 10/7/2008 4:17 PM EDT Dow Sinks 500 Points as Credit Fears Persist 10/7/2008 4:06 PM EDT More News from TheStreet.com ETFs Small Business Investing A-Z Life and Money Moneymaking Strategies Corning Braces for Economic Uncertainty The company says it's prepared...
The Washington Times (Free subscription) | yesterday
Stocks that moved substantially or traded heavily Tuesday on the New York Stock Exchange and Nasdaq Stock Market:
